Kirkland & Ellis
Sarkis Jebejian
- Deals
- 3
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Kirkland & Ellis Law firm · 2026 · 3 deals
Often works with
- Steven Choi 2 deals together
- Dean Shulman 2 deals together
- Liam Murphy 2 deals together
- Samantha Morelli 2 deals together
- Shellie Freedman 2 deals together
- Rami Sherman 2 deals together
- Keri Schick Norton 2 deals together
- Allie Wein 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | Cursor | – | SpaceX | Acquisition | Legal adviser to Cursor (target) | Announced | 60,000.0 | AI+1 | SpaceX acquisition of Cursor |
| May 2026 | LimmaTech Biologics AG | – | Eli Lilly and Company | Acquisition | Legal adviser to Eli Lilly and Company (acquirer) | Pending | 780.0 | Biotech | Eli Lilly and Company acquisition of LimmaTech Biologics AG |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Eli Lilly and Company (acquirer) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
Deals where Sarkis Jebejian is named on the firm's deal team, by the firm or the press.